TORONTO, Aug. 28, 2018 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (TSX VENTURE: RVV) (OTCQB: RVVTF) (FSE: 31R) (“Reviveâ€� or the “Companyâ€�), a specialty cannabis company focused on the research, development and commercialization of novel cannabinoid-based products, is pleased to provide a corporate update on its product strategy and business development activities in its objective in […]

by

TORONTO, Aug. 22, 2018 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (TSX VENTURE:RVV) (OTCQB:RVVTF) (FSE:31R) (“Revive” or the “Company”), a specialty medical cannabis company, today announced that it has submitted an application to the U.S. Food and Drug Administration (“FDA”) seeking orphan drug designation of cannabidiol (“CBD”) for the treatment of hepatic ischemia and reperfusion injury […]

by

Copyright 2018 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. Copyright 2018 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. DES MOINES – The Department of Public Health (IDPH) has received a number of questions about the legality of CBD […]

by

Warr Acres Mayor Jim Mickley in his office. (Photo by Emmy Verdin) OKLAHOMA CITY – Municipalities across Oklahoma are trying to determine whether they need to echo new state laws on medical marijuana or establish more conservative rules of their own. The City Council of Warr Acres, for example, recently passed an amendment to existing […]

by

Cannabis world domination.Sara Brittany Somerset As the marijuana business grows globally, many stock watchers and research analysts are making predictions about where the most significant investment opportunities are. Investment site The Motley Fool recently published an analysis by Keith Speights of forecasts for the 2022 marijuana market. A lot can happen even monthly in the ever-evolving […]

by

Copyright 2018 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. Copyright 2018 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. DES MOINES – The Department of Public Health (IDPH) has received a number of questions about the legality of CBD […]

by

Cannabis world domination graphic art.Sara Brittany Somerset As marijuana business grows globally, many stock watchers and research analysts are making predictions about where the most significant investment opportunities are.  Investment site, The Motley Fool, recently published an analysis by Keith Speights of forecasts for the 2022 marijuana market. A lot can happen even monthly in the […]

by

Cannabis world domination graphic art.Sara Brittany Somerset As marijuana business grows globally, many stock watchers and research analysts are making predictions about where the most significant investment opportunities are.  Investment site, The Motley Fool, recently published an analysis by Keith Speights of forecasts for the 2022 marijuana market. A lot can happen even monthly in the […]

by

Aug. 13 (UPI) — Cannabidiol, a drug derived from marijuana, was effective at treating patients with treatment-resistant epilepsy. Researchers at the University of Alabama at Birmingham found that cannabidiol, or CBD oil, reduced the number of seizures among patients who did not respond to traditional treatments. Their findings were published last week in the journal […]

by

Carmen Navarrete, PhD, has been granted a Scientific Innovation Award for her post-doctoral presentation suggesting that the multiple sclerosis (MS) treatment candidate EHP-101 is anti-inflammatory and may boost remyelination, Emerald Health Pharmaceuticals announced. Navarrete, a senior scientist at Vivacell Biotechnology Espana, a company owned by Emerald Health Research, received the award at the 28th Annual International Cannabinoid Research Society (ICRS) Symposium, […]

by

Revive Therapeutics submitted an application to the FDA for an orphan drug designation to its CBD treatment of hepatic ischemia and reperfusion injury during liver transplantation. Revive Therapeutics (TSXV:RVV) submitted an application to the US Food and Drug Administration (FDA) for an orphan drug designation to its cannabidiol (CBD) treatment of hepatic ischemia and reperfusion injury (IRI) during liver […]

by